Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.47 |
| ▸ | MEN1 | O00255 | 6/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.47 |
| ▸ | BLM | P54132 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | MAPT | P10636 | 5/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31741233 | 1.00 | TERT (0.59) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL1259938 | 0.98 | TERT (0.58) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL29549001 | 0.98 | TERT (0.61) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL3899512 | 0.98 | TERT (0.61) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Perchlorate SCHEMBL891055 | 0.92 | TERT (0.54) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL4856935 | 0.88 | TERT (0.50) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL94357 | 0.81 | TERT (0.58) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| SCHEMBL5114156 | 0.81 | TERT (0.43) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL2477629 | 0.80 | TERT (0.56) | TERTL3MBTL1MEN1KMT2ANPC1 | |
| Hydrochloric Acid SCHEMBL2479389 | 0.80 | TERT (0.56) | TERTL3MBTL1MEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4263932-A1 | PRINTING OF FIBER BLENDS, WOVEN AND NON-WOVEN OR KNIT FABRIC | Archroma IP GmbH (CH) | 2023-10-25 | — | — | EP | disclosed |
| US-20230313450-A1 | PRINTING OF FIBER BLENDS, WOVEN AND NON-WOVEN OR KNIT FABRIC | ARCHROMA IP GMBH (CH) | 2023-10-05 | — | — | US | disclosed |
| CN-116693886-A | Boric acid esterification crosslinked sodium carboxymethyl cellulose hydrogel | 浙江工业大学 | 2023-09-05 | — | — | CN | disclosed |
| CN-116368274-A | Printing of fiber mixtures, woven and non-woven or knitted fabrics | 昂高知识产权有限公司 | 2023-06-30 | — | — | CN | disclosed |
| WO-2022129486-A1 | PRINTING OF FIBER BLENDS, WOVEN AND NON-WOVEN OR KNIT FABRIC | ARCHROMA IP GMBH (CH) | 2022-06-23 | — | — | WO | disclosed |
| US-10589003-B2 | Methods for coating surfaces with antimicrobial agents | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2020-03-17 | — | — | US | disclosed |
| US-20180303977-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-10-25 | — | — | US | disclosed |
| US-7713472-B2 | Antiseptic derivatives with broad spectrum antimicrobial activity for the impregnation of surfaces | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-05-11 | — | — | US | disclosed |
| US-7651661-B2 | Medical devices with broad spectrum antimicrobial activity | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-01-26 | — | — | US | disclosed |
| US-20080183152-A1 | MEDICAL DEVICES WITH BROAD SPECTRUM ANTIMICROBIAL ACTIVITY | RAAD ISSAM | 2008-07-31 | — | — | US | disclosed |
| US-20070154621-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2007-07-05 | — | — | US | disclosed |
| US-20050197634-A1 | Methods for coating and impregnating medical devices with antiseptic compositions | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2005-09-08 | — | — | US | disclosed |
| US-5741662-A | Direct stain specific binding assays for microorganisms | QUIDEL CORPORATION (US) | 1998-04-21 | — | — | US | disclosed |
| WO-1997022714-A1 | DIRECT STAIN SPECIFIC BINDING ASSAYS FOR MICROORGANISMS | QUIDEL CORPORATION (US) | 1997-06-26 | — | — | WO | disclosed |
| US-5240780-A | Pressure sensitive adhesives | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1993-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10589003-B2 | Methods for coating surfaces with antimicrobial agents | CUTA, CD63, CDC37 | TERT 1125/4885L3MBTL1 4345/4885MEN1 4111/4885 |
| US-20180303977-A1 | METHODS FOR COATING SURFACES WITH ANTIMICROBIAL AGENTS | CUTA, CD63, CDC37 | TERT 1125/4885L3MBTL1 4345/4885MEN1 4111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.